Related Experiment Video
Updated: Jun 1, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
The clinical syndrome of bilirubin-induced neurologic dysfunction
Lois Johnson1, Vinod K Bhutani
1Pennsylvania Center for Kernicterus, Philadelphia, PA, USA.
Insights
Bilirubin-induced neurologic dysfunction (BIND) may affect infants with moderate hyperbilirubinemia, causing subtle neurodevelopmental issues. Early assessment tools are needed for at-risk infants.
Area of Science:
- Neonatology
- Neurodevelopmental Pediatrics
- Pediatric Neurology
Background:
- Bilirubin-induced neurologic dysfunction (BIND) is traditionally associated with severe hyperbilirubinemia.
- Subtle neurodevelopmental deficits may occur in infants with less severe hyperbilirubinemia exposure.
Purpose of the Study:
- To propose that BIND encompasses a spectrum of neurologic manifestations in vulnerable infants.
- To highlight the need for improved assessment tools for BIND.
Main Methods:
- Review of clinical manifestations of BIND.
- Identification of confounding factors influencing BIND.
- Proposal for development of assessment tools for BIND.
Main Results:
- BIND may present with subtle processing disorders affecting visual-motor, auditory, speech, cognition, and language.
- Factors like prematurity, hemolysis, and bilirubin-albumin binding influence BIND.
- Current diagnostic criteria may underestimate the full spectrum of BIND.
Conclusions:
- BIND represents a spectrum of neurodevelopmental issues in infants exposed to varying degrees of hyperbilirubinemia.
- Multisensory processing disorders are key manifestations of BIND.
- Development of specific assessment tools is crucial for early detection and surveillance of at-risk infants.
Abstract:
We believe that the syndrome of bilirubin-induced neurologic dysfunction [BIND] represents a spectrum of neurologic manifestations among vulnerable infants who have experienced an exposure to bilirubin of lesser degree than generally described in previous publications. Clinical neuro-motor manifestations extend to a range of subtle processing disorders with objective disturbances of visual-motor, auditory, speech, cognition, and language among infants with a previous history of moderate-to-severe hyperbilirubinemia of varied duration. Confounding effects include prematurity, hemolysis, perinatal-neonatal complications, altered bilirubin-albumin binding, severity and duration of bilirubin exposure, and the individual vulnerability of the infant related to genetic, family, social, and educational predilection, regardless of the cause of neonatal jaundice. Tools to better assess BIND specific domains of multisensory processing disorders, identified by pyschometric, audiologic, speech, language and visual-motor, and neuromotor examination would allow for prospective surveillance of infants at risk for the syndrome.
Related Concept Videos
Hepatic Encephalopathy
Jaundice
Encephalitis ll: Pathophysiology
Botulism
Encephalitis l: Introduction
Cirrhosis I: Introduction

